Navigation Links
MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R)
Date:8/26/2009

uce Nicholson, a leading pain physician in the US, commented on these results: "The concept of combining morphine and oxycodone makes sense based on the clinical data generated to date, and has benefited my patients in managing their acute and chronic pain needs. Results of this study reinforce that the clinical advantages of MoxDuo(TM) IR have the potential to change the traditional methods of treating moderate to severe pain by providing better pain relief without many of the debilitating side effects seen with traditional opioid drugs."

Based on the Company's July 2008 FDA meeting, final Phase 3 studies for MoxDuo(TM) IR will include: (1) a "double-blind combination rule" trial in patients experiencing post-surgical (bunionectomy) pain that compares MoxDuo(TM) IR against morphine alone and oxycodone alone and (2) a double-blind controlled study to evaluate the effectiveness of MoxDuo(TM) IR in patients following total knee replacement. No additional pharmacology, toxicology or long-term clinical safety studies will be required for regulatory submission and market approval.

Forward Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. The forward-looking statements contained herein represent the judgment of QRxPharma as of the date of this release. These forward-looking statements are not guarantees for future performance. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the stage of products under development; uncertainties relating to clinical trials; dependence on third parties; future capital needs; and risks relating to the commercialisation of the Company's proposed products.

About QRxPharma

QRxPharma (ASX: QRX) and (OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the developme
'/>"/>

SOURCE QRxPharma Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients
2. Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class
3. Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
4. Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
5. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
6. Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
7. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
8. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
9. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
10. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
11. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... PALO ALTO, Calif. , Sept. 30, 2014 ... early-stage investment group focused on supporting promising emerging ... companies, has been named the Top Angel Investment ... CB Insights as the best performer out of ... that included: historical performance, network strength (connections), selection ...
(Date:9/30/2014)... DIEGO , Sept. 30, 2014 ... three-dimensional biology company focused on delivering breakthrough 3D ... Liver Model has been selected as a finalist in ... 2014 Most Innovative New Product Awards, sponsored by ... of innovative technology and life sciences products in ...
(Date:9/30/2014)... Inc. ( www.synapsebiomedical.com ) announced today it has ... its NeuRx DPS® System for ALS patients.  The ... requirement was implanted over a month and a ... is the only medical device approved by the ... device that obtained approval at the end of ...
Breaking Medicine Technology:Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3
... RYE, N.Y., Oct. 14 Curemark, LLC, a drug research ... announced that it has enrolled the first patients in Phase ... first clinical trial patients have been enrolled at Lake Mary ... sites with a total 170 children across the country. , ...
... Cardiva Medical, Inc. announces today that its President, Glenn ... Chief Executive Officer at Innovative Energy, Inc., an alternative energy ... Medical stated, "I would like to thank Glenn for his ... his tenure as President, we have transformed Cardiva from an ...
Cached Medicine Technology:Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment 2Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc. 2Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc. 3
(Date:9/30/2014)... AutoTex PINK proudly offers pink ... in support of breast cancer awareness and research in ... non-profits to “go pink” -- supporting walks, runs and ... a woman-owned company that is among the nation’s leading ... partnering with their customers to raise breast cancer awareness ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Teeth replacement ... Dental Art Institute in Oxnard and Thousand Oaks, Calif., ... and tomorrow to provide training on full mouth rehabilitation. ... work, placing implants, providing cosmetic dentistry, correcting bite issues, ... said. , Dr. Jivraj, who has traveled to India ...
(Date:9/30/2014)... September 30, 2014 Loffler Companies, ... business technology and services was recognized by BEI ... Effectiveness (FCE) in 2013. This prestigious rating means ... first time and for an extended period following, ... than 20 years BEI Services has been the ...
(Date:9/30/2014)... In honor of National Breast Cancer Awareness ... courageous battles, Incredible Veins, Body & Skin is offering ... Cynosure. , “For cancer patients who receive radiation ... on their skin to accurately aim the radiation on ... survivors, they decide to have their tattoo removed as ...
(Date:9/30/2014)... 30, 2014 Julie Kuriakose, ... Allergy , will discuss how restaurants can become more ... special dietary restrictions at the 2014 Allergy Eats ... Professionals, October 21 in New York City. , “I’m ... topic to such an engaged industry audience. As food ...
Breaking Medicine News(10 mins):Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 2Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 3Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 2Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 3Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 4Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 5Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 2Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 3Health News:Incredible Veins, Body & Skin Takes A Stand Against Breast Cancer With PicoSure® By Cynosure 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 3
... Children,s Health Fund (CHF) strongly supports the health ... its steadfast commitment to this momentous effort.  We believe that ... especially for children.  The action taken shows an unprecedented effort ... well-being of all children in this country.  CHF thanks House ...
... ) today announced it will participate in the Barclays Capital 2010 High Yield Bond and Syndicated Loan Conference in Phoenix, Ariz. , on March 24-26, 2010 . , ... , ... ... ...
... Living wills and surrogate decision makers account for only ... making medical decisions for hospitalized patients lacking the capability to ... Researchers who queried 281 physicians report their conclusions ... of the Journal of the American Geriatrics Society . ...
... AF Stat a collaboration of healthcare leaders ... of people affected by atrial fibrillation (AFib) today ... widget to help healthcare practitioners better explain the risks ... The most common form of heart arrhythmia, AFib affects ...
... , ... the launch of Website Realizer, an efficient solution to reduce the costs for building a ... looking website without writing a single line of code. , ... (PRWEB) March 22, 2010 -- Adritech Software has announced the ...
... fewer irritants than lighter brews, researchers find , ... coffee-lovers with delicate stomachs, scientists may have found a ... gastrointestinal discomfort. , European researchers studying stomach-irritating chemicals in ... production in the stomach. , "The major import of ...
Cached Medicine News:Health News:Statement by Irwin Redlener, MD, President, Children's Health Fund on Passage of a Health Care Reform Package by the House 2Health News:Statement by Irwin Redlener, MD, President, Children's Health Fund on Passage of a Health Care Reform Package by the House 3Health News:HealthSouth To Present at Barclays Capital 2010 High Yield Bond and Syndicated Loan Conference 2Health News:HealthSouth To Present at Barclays Capital 2010 High Yield Bond and Syndicated Loan Conference 3Health News:Numerous factors weighed when patients cannot make their own decisions 2Health News:'AFib Educator' app and widget offers patient dialogue tool for complex cardiovascular disease 2Health News:Adritech Software Releases Website Realizer, a Website Builder to Create Websites without Any Programming Knowledge 2Health News:Coming Soon: A Low-Heartburn Coffee? 2Health News:Coming Soon: A Low-Heartburn Coffee? 3
The WatchMate ID model displays multiple alarms locally with resident ID numbers and this information, along with residents names, can be displayed at a central station. Alarms may be cleared locall...
... Radianse indoor positioning ... measure of where and ... patients flow through care ... data provides intelligence that ...
... supports patient safety by providing patient ... patients are in the right place ... the exact patient location when a ... Measure patient flow times to identify ...
... VACUETTE Blood Collection Needles are preominantly used ... for single-use. The colour of the needle ... individual needle gauges. For example, yellow symbolises ... green 21 G (0.80 mm) and black ...
Medicine Products: